The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Drug safety evaluation, also known as non-clinical drug safety evaluation, refers to the evaluation of the safety of therapeutic drugs through laboratory research and animal in vitro systems. It is a necessary procedure and important step before new drugs enter final clinical trials and final approval. . Drug safety must first be drafted protocols and protocols. These studies, such as general acute chronic toxicity studies, pathohistological studies, reproductive toxicity tests, genotoxicity studies, safety pharmacology studies, investigation studies, and toxicity and safety biomarker studies. Due to the volume of the very successful methods in the Molecular Biology series, the chapters include a brief introduction to the respective disciplines, a list of required materials, a step-by-step, repeatable protocol, and tips on troubleshooting and avoiding known pitfalls.
The global Drug Safety Solutions and Pharmacovigilance market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Safety Solutions and Pharmacovigilance, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Safety Solutions and Pharmacovigilance.
Report Scope
The Drug Safety Solutions and Pharmacovigilance market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Safety Solutions and Pharmacovigilance market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Safety Solutions and Pharmacovigilance companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List):
- Pharmaceutical Product Development, LLC
- Drug Safety Solutions Limited
- C3i
- Worldwide Clinical Trials
- Bioclinica
- United Biosource LLC
- Ennov
- AB Cube
- Covance Inc.
- Accenture
- PRA Health Sciences, Inc.
- Ergomed
- IQVIA
- Genpact
- Cognizant
- Parexel International Corporation
- ArisGlobal
- ICON plc
- Oracle
- Syneos Health
Segment by Type
- Standard Form
- Customized Form
Segment by Application
- Biotechnology and Pharmaceuticals
- Contract Research Organization (CROS)
- Hospital
- KPO / BPO
- Healthcare Institutions
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Safety Solutions and Pharmacovigilance companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Standard Form
1.2.3 Customized Form
1.3 Market by Application
1.3.1 Global Drug Safety Solutions and Pharmacovigilance Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology and Pharmaceuticals
1.3.3 Contract Research Organization (CROS)
1.3.4 Hospital
1.3.5 KPO / BPO
1.3.6 Healthcare Institutions
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Safety Solutions and Pharmacovigilance Market Perspective (2019-2030)
2.2 Drug Safety Solutions and Pharmacovigilance Growth Trends by Region
2.2.1 Global Drug Safety Solutions and Pharmacovigilance Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Safety Solutions and Pharmacovigilance Historic Market Size by Region (2019-2024)
2.2.3 Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Region (2025-2030)
2.3 Drug Safety Solutions and Pharmacovigilance Market Dynamics
2.3.1 Drug Safety Solutions and Pharmacovigilance Industry Trends
2.3.2 Drug Safety Solutions and Pharmacovigilance Market Drivers
2.3.3 Drug Safety Solutions and Pharmacovigilance Market Challenges
2.3.4 Drug Safety Solutions and Pharmacovigilance Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Safety Solutions and Pharmacovigilance Players by Revenue
3.1.1 Global Top Drug Safety Solutions and Pharmacovigilance Players by Revenue (2019-2024)
3.1.2 Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Players (2019-2024)
3.2 Global Drug Safety Solutions and Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Safety Solutions and Pharmacovigilance Revenue
3.4 Global Drug Safety Solutions and Pharmacovigilance Market Concentration Ratio
3.4.1 Global Drug Safety Solutions and Pharmacovigilance Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Safety Solutions and Pharmacovigilance Revenue in 2023
3.5 Drug Safety Solutions and Pharmacovigilance Key Players Head office and Area Served
3.6 Key Players Drug Safety Solutions and Pharmacovigilance Product Solution and Service
3.7 Date of Enter into Drug Safety Solutions and Pharmacovigilance Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Safety Solutions and Pharmacovigilance Breakdown Data by Type
4.1 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Type (2019-2024)
4.2 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Type (2025-2030)
5 Drug Safety Solutions and Pharmacovigilance Breakdown Data by Application
5.1 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Application (2019-2024)
5.2 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Safety Solutions and Pharmacovigilance Market Size (2019-2030)
6.2 North America Drug Safety Solutions and Pharmacovigilance Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2019-2024)
6.4 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size (2019-2030)
7.2 Europe Drug Safety Solutions and Pharmacovigilance Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2019-2024)
7.4 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size (2019-2030)
8.2 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Safety Solutions and Pharmacovigilance Market Size (2019-2030)
9.2 Latin America Drug Safety Solutions and Pharmacovigilance Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2019-2024)
9.4 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size (2019-2030)
10.2 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pharmaceutical Product Development, LLC
11.1.1 Pharmaceutical Product Development, LLC Company Detail
11.1.2 Pharmaceutical Product Development, LLC Business Overview
11.1.3 Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Introduction
11.1.4 Pharmaceutical Product Development, LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.1.5 Pharmaceutical Product Development, LLC Recent Development
11.2 Drug Safety Solutions Limited
11.2.1 Drug Safety Solutions Limited Company Detail
11.2.2 Drug Safety Solutions Limited Business Overview
11.2.3 Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Introduction
11.2.4 Drug Safety Solutions Limited Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.2.5 Drug Safety Solutions Limited Recent Development
11.3 C3i
11.3.1 C3i Company Detail
11.3.2 C3i Business Overview
11.3.3 C3i Drug Safety Solutions and Pharmacovigilance Introduction
11.3.4 C3i Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.3.5 C3i Recent Development
11.4 Worldwide Clinical Trials
11.4.1 Worldwide Clinical Trials Company Detail
11.4.2 Worldwide Clinical Trials Business Overview
11.4.3 Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Introduction
11.4.4 Worldwide Clinical Trials Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.4.5 Worldwide Clinical Trials Recent Development
11.5 Bioclinica
11.5.1 Bioclinica Company Detail
11.5.2 Bioclinica Business Overview
11.5.3 Bioclinica Drug Safety Solutions and Pharmacovigilance Introduction
11.5.4 Bioclinica Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.5.5 Bioclinica Recent Development
11.6 United Biosource LLC
11.6.1 United Biosource LLC Company Detail
11.6.2 United Biosource LLC Business Overview
11.6.3 United Biosource LLC Drug Safety Solutions and Pharmacovigilance Introduction
11.6.4 United Biosource LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.6.5 United Biosource LLC Recent Development
11.7 Ennov
11.7.1 Ennov Company Detail
11.7.2 Ennov Business Overview
11.7.3 Ennov Drug Safety Solutions and Pharmacovigilance Introduction
11.7.4 Ennov Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.7.5 Ennov Recent Development
11.8 AB Cube
11.8.1 AB Cube Company Detail
11.8.2 AB Cube Business Overview
11.8.3 AB Cube Drug Safety Solutions and Pharmacovigilance Introduction
11.8.4 AB Cube Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.8.5 AB Cube Recent Development
11.9 Covance Inc.
11.9.1 Covance Inc. Company Detail
11.9.2 Covance Inc. Business Overview
11.9.3 Covance Inc. Drug Safety Solutions and Pharmacovigilance Introduction
11.9.4 Covance Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.9.5 Covance Inc. Recent Development
11.10 Accenture
11.10.1 Accenture Company Detail
11.10.2 Accenture Business Overview
11.10.3 Accenture Drug Safety Solutions and Pharmacovigilance Introduction
11.10.4 Accenture Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.10.5 Accenture Recent Development
11.11 PRA Health Sciences, Inc.
11.11.1 PRA Health Sciences, Inc. Company Detail
11.11.2 PRA Health Sciences, Inc. Business Overview
11.11.3 PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Introduction
11.11.4 PRA Health Sciences, Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.11.5 PRA Health Sciences, Inc. Recent Development
11.12 Ergomed
11.12.1 Ergomed Company Detail
11.12.2 Ergomed Business Overview
11.12.3 Ergomed Drug Safety Solutions and Pharmacovigilance Introduction
11.12.4 Ergomed Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.12.5 Ergomed Recent Development
11.13 IQVIA
11.13.1 IQVIA Company Detail
11.13.2 IQVIA Business Overview
11.13.3 IQVIA Drug Safety Solutions and Pharmacovigilance Introduction
11.13.4 IQVIA Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.13.5 IQVIA Recent Development
11.14 Genpact
11.14.1 Genpact Company Detail
11.14.2 Genpact Business Overview
11.14.3 Genpact Drug Safety Solutions and Pharmacovigilance Introduction
11.14.4 Genpact Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.14.5 Genpact Recent Development
11.15 Cognizant
11.15.1 Cognizant Company Detail
11.15.2 Cognizant Business Overview
11.15.3 Cognizant Drug Safety Solutions and Pharmacovigilance Introduction
11.15.4 Cognizant Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.15.5 Cognizant Recent Development
11.16 Parexel International Corporation
11.16.1 Parexel International Corporation Company Detail
11.16.2 Parexel International Corporation Business Overview
11.16.3 Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Introduction
11.16.4 Parexel International Corporation Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.16.5 Parexel International Corporation Recent Development
11.17 ArisGlobal
11.17.1 ArisGlobal Company Detail
11.17.2 ArisGlobal Business Overview
11.17.3 ArisGlobal Drug Safety Solutions and Pharmacovigilance Introduction
11.17.4 ArisGlobal Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.17.5 ArisGlobal Recent Development
11.18 ICON plc
11.18.1 ICON plc Company Detail
11.18.2 ICON plc Business Overview
11.18.3 ICON plc Drug Safety Solutions and Pharmacovigilance Introduction
11.18.4 ICON plc Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.18.5 ICON plc Recent Development
11.19 Oracle
11.19.1 Oracle Company Detail
11.19.2 Oracle Business Overview
11.19.3 Oracle Drug Safety Solutions and Pharmacovigilance Introduction
11.19.4 Oracle Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.19.5 Oracle Recent Development
11.20 Syneos Health
11.20.1 Syneos Health Company Detail
11.20.2 Syneos Health Business Overview
11.20.3 Syneos Health Drug Safety Solutions and Pharmacovigilance Introduction
11.20.4 Syneos Health Revenue in Drug Safety Solutions and Pharmacovigilance Business (2019-2024)
11.20.5 Syneos Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
